Literature DB >> 26876120

Genetic and Developmental Basis of Cardiovascular Malformations.

Mohamad Azhar1, Stephanie M Ware2.   

Abstract

Cardiovascular malformations (CVMs) are the most common birth defect, occurring in 1% to 5% of all live births. Genetic, epigenetic, and environmental factors all influence the development of CVMs, and an improved understanding of the causation of CVMs is a prerequisite for prevention. Cardiac development is a complex, multistep process of morphogenesis that is under genetic regulation. Although the genetic contribution to CVMs is well recognized, the genetic causes of human CVMs are still identified infrequently. This article discusses the key genetic concepts characterizing human CVMs, their developmental basis, and the critical developmental and genetic concepts underlying their pathogenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital heart defects; Congenital heart disease; Development; Gene dosage

Mesh:

Year:  2016        PMID: 26876120      PMCID: PMC5215107          DOI: 10.1016/j.clp.2015.11.002

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  47 in total

Review 1.  TGFβ signaling and congenital heart disease: Insights from mouse studies.

Authors:  Helen M Arthur; Simon D Bamforth
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-04-28

2.  Clinical Stratification of Pediatric Patients with Idiopathic Thoracic Aortic Aneurysm.

Authors:  Benjamin J Landis; Stephanie M Ware; Jeanne James; Amy R Shikany; Lisa J Martin; Robert B Hinton
Journal:  J Pediatr       Date:  2015-03-24       Impact factor: 4.406

3.  Congenital heart disease: entering a new era of human genetics.

Authors:  Benoit G Bruneau; Deepak Srivastava
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

Review 4.  Genetic basis of congenital cardiovascular malformations.

Authors:  Seema R Lalani; John W Belmont
Journal:  Eur J Med Genet       Date:  2014-04-30       Impact factor: 2.708

Review 5.  Heart fields and cardiac morphogenesis.

Authors:  Robert G Kelly; Margaret E Buckingham; Antoon F Moorman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-01       Impact factor: 6.915

Review 6.  Epigenetics and cardiovascular development.

Authors:  Ching-Pin Chang; Benoit G Bruneau
Journal:  Annu Rev Physiol       Date:  2011-10-24       Impact factor: 19.318

7.  Elastin haploinsufficiency results in progressive aortic valve malformation and latent valve disease in a mouse model.

Authors:  Robert B Hinton; Jennifer Adelman-Brown; Sandra Witt; Varun K Krishnamurthy; Hanna Osinska; Bhuvaneswari Sakthivel; Jeanne F James; Dean Y Li; Daria A Narmoneva; Robert P Mecham; D Woodrow Benson
Journal:  Circ Res       Date:  2010-06-24       Impact factor: 17.367

Review 8.  Investigating the transcriptional control of cardiovascular development.

Authors:  Irfan S Kathiriya; Elphège P Nora; Benoit G Bruneau
Journal:  Circ Res       Date:  2015-02-13       Impact factor: 17.367

Review 9.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

Review 10.  Loeys-Dietz syndrome: a primer for diagnosis and management.

Authors:  Gretchen MacCarrick; James H Black; Sarah Bowdin; Ismail El-Hamamsy; Pamela A Frischmeyer-Guerrerio; Anthony L Guerrerio; Paul D Sponseller; Bart Loeys; Harry C Dietz
Journal:  Genet Med       Date:  2014-02-27       Impact factor: 8.822

View more
  12 in total

1.  Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease.

Authors:  Madhumita Basu; Jun-Yi Zhu; Stephanie LaHaye; Uddalak Majumdar; Kai Jiao; Zhe Han; Vidu Garg
Journal:  JCI Insight       Date:  2017-10-19

Review 2.  Heart Failure in Pediatric Patients With Congenital Heart Disease.

Authors:  Robert B Hinton; Stephanie M Ware
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

3.  A Common Polymorphism in the MTHFD1 Gene Is a Modulator of Risk of Congenital Heart Disease.

Authors:  Nataša Karas Kuželički; Alenka Šmid; Maša Vidmar Golja; Tina Kek; Borut Geršak; Uroš Mazič; Irena Mlinarič-Raščan; Ksenija Geršak
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-24

Review 4.  Epigenetics and Congenital Heart Diseases.

Authors:  Léa Linglart; Damien Bonnet
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-09

5.  Fluoxetine Inhibits Canonical Wnt Signaling to Impair Embryoid Body Morphogenesis: Potential Teratogenic Mechanisms of a Commonly Used Antidepressant.

Authors:  Erica L L Warkus; Yusuke Marikawa
Journal:  Toxicol Sci       Date:  2018-10-01       Impact factor: 4.849

6.  Copy number variations in the GATA4, NKX2-5, TBX5, BMP4 CRELD1, and 22q11.2 gene regions in Chinese children with sporadic congenital heart disease.

Authors:  Zhetao Li; Jiwei Huang; Biao Liang; Dingyuan Zeng; Shiqiang Luo; Tizhen Yan; Fengwen Liao; Jun Huang; Jingwen Li; Ren Cai; Xine Deng; Ning Tang
Journal:  J Clin Lab Anal       Date:  2018-09-17       Impact factor: 2.352

7.  Reduced dosage of β-catenin provides significant rescue of cardiac outflow tract anomalies in a Tbx1 conditional null mouse model of 22q11.2 deletion syndrome.

Authors:  Silvia E Racedo; Erica Hasten; Mingyan Lin; Gnanapackiam Sheela Devakanmalai; Tingwei Guo; Ertugrul M Ozbudak; Chen-Leng Cai; Deyou Zheng; Bernice E Morrow
Journal:  PLoS Genet       Date:  2017-03-27       Impact factor: 5.917

Review 8.  Genetic evaluation of patients with congenital heart disease.

Authors:  Gabrielle C Geddes; Michael G Earing
Journal:  Curr Opin Pediatr       Date:  2018-12       Impact factor: 2.856

9.  The developmental origins of sex-biased expression in cardiac development.

Authors:  Daniel F Deegan; Reza Karbalaei; Jozef Madzo; Rob J Kulathinal; Nora Engel
Journal:  Biol Sex Differ       Date:  2019-09-05       Impact factor: 5.027

Review 10.  Genetics of Congenital Heart Disease.

Authors:  Kylia Williams; Jason Carson; Cecilia Lo
Journal:  Biomolecules       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.